← Leaderboards
Thomas Schulte
Nexgenia, Inc.
$699,213
Attributed
$699,213
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $503.1K · FY2012–13$1M$750K$500K$250K$0
'12
'13
Funding mix
By agency
NIH$699,213 · 2
By mechanism
R44$503,079 · 1
R43$196,134 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesAntibody ConjugateAqueousAreaBinding (Molecular Function)Biological SciencesBiomarkerCaliberCarboxylateCaringCellsChemistryCommercializationCommunicable DiseasesDiagnosticDiffuseDiffusionDimensionsEndocrine System DiseasesEnsureEnzyme-Linked Immunosorbent AssayEvaluationExhibitsAnesthesia Procedures